NASDAQ:NBIX

Soleno Stock Delisted From Nasdaq After $2.9 Billion Neurocrine Deal
·····

Soleno Stock Delisted From Nasdaq After $2.9 Billion Neurocrine Deal

Neurocrine Biosciences completed its $2.9 billion cash acquisition of Soleno Therapeutics, delisting Soleno from Nasdaq after a $53-per-share payout. The merger closed May 18, following a tender offer that secured 88.9% of Soleno shares. VYKAT XR, Soleno’s FDA-approved drug for Prader-Willi syndrome, generated $190 million in 2025 revenue. Nasdaq will next open after Memorial Day on Tuesday.
May 23, 2026

Stock Market Today

  • Rise in Interest for ASX Semiconductor ETF Amid Tech Demand
    May 29, 2026, 10:13 PM EDT. An Australian Securities Exchange (ASX) semiconductor exchange-traded fund (ETF) is attracting increased investor attention due to the ongoing growth in the technology sector. ETFs offer exposure to a basket of semiconductor stocks, providing diversified investment in chipmakers integral to industries from consumer electronics to automotive technologies. Market participants are watching this ETF closely amid rising demand for semiconductor components worldwide. Investors are advised to conduct due diligence and consult financial advisers before investment decisions, as content from financial media services like Kalkine Media is for educational purposes and not investment advice.